Nucleoside-modified mRNA-LNP vaccine for SARS-CoV-2
Drew Weissman, M.D., Ph.D., Professor of Medicine- University of Pennsylvania
10 events found.
Events
-
-
Zoom Seminar Series
-
Evolution of SARS-CoV-2 Before and During the Pandemic
Zoom Seminar SeriesBette Korber, M.D., Los Alamos National Laboratory
-
HIV Neutralizing Antibody CAP256V2LS: From Sorting B Cells to Filling Vials
Zoom Seminar SeriesNicole Doria-Rose, Ph.D., Staff Scientist, Chief, Humoral Immunology Core, Vaccine Research Center- NIH
-
-
Identifying cross-stage and cross-species malaria T cell epitopes
Zoom Seminar SeriesCaroline Junqueira, Ph.D., Associate Professor, Oswaldo Cruz Foundation (Fiocruz)-Brazil- Research Associate, Program in Cellular and Molecular Medicine at Boston Children’s Hospital/ Harvard Medical School
-
CD8+ T cell recirculation in humans
Zoom Seminar SeriesMichael R. Betts, Ph.D., Professor, University of PennsylvaniaPerelman School of Medicine, Department of Microbiology. Director, CAMB-MVP Graduate Group
-
Neutralizing antibody responses to SARS-CoV-2
Zoom Seminar SeriesTheodora Hatziioannou, Ph.D., Research Associate Professor- Rockefeller University
-
Fab-dimerized glycan-reactive antibodies; a new structural category of natural antibodies
Zoom Seminar SeriesBarton F. Haynes, M.D., Director, Duke Human Vaccine Institute, Frederic M. Hanes Professor of Medicine, Professor of Immunology and Global Health- Duke University Medical Center
-
-
Systems Serology to Define Humoral Correlates of Immunity to SARS-CoV-2
Zoom Seminar SeriesGalit Alter, Ph.D.- Professor of Medicine- HMS, Group Leader- The Ragon Institute of MGH, MIT and Harvard
-
Skin and Vaccine Biology
Zoom Seminar SeriesThomas S. Kupper, M.D., Fitzpatrick Professor and Chair, Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School
-
Deloping a COVID-19 vaccine and ensuring that everyone can get it
FeaturedWhen will there be an effective vaccine for COVID-19? How will it work? And how will it be distributed? Jonathan Saltzman, the Globe's biotechnology and life sciences reporter, will interview a panel of specialists about what's happening in clinical trials of potential vaccines, how long testing will last, and how to make sure that everyone […]
